trending Market Intelligence /marketintelligence/en/news-insights/trending/_8NdmaRxSYRYkXybFucruw2 content esgSubNav
In This List

Transgenomic, Precipio merger secures stockholder approval

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Transgenomic, Precipio merger secures stockholder approval

Transgenomic Inc. received stockholder approval for its proposed merger with Precipio Diagnostics LLC.

Precipio Diagnostics stockholders also approved the deal.

The closing of the merger is still pending the combined company's $7 million private placement of preferred convertible securities and the conversion of all outstanding secured debt into preferred convertible securities.

The combined company will be renamed Precipio Inc. and be relisted on Nasdaq under the PRPO ticker symbol.